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Rickettsia are intracellular Proteobacteria
associated with arthropods, including body lice,
fleas, ticks, and mites (1). R. typhi, the agent of
murine typhus, is transmitted by rat fleas,
Xenopsylla cheopsis. In 1990, when cat fleas
(Ctenocephalides felis) were examined as pos-
sible vectors of R. typhi, a novel Rickettsia-like
organism was observed by electron microscopy in
midgut epithelial cells of the fleas. The agent,
named the ELB agent for the EL Laboratory
(Soquel, CA) (2), was detected in 1994 and 2000
by polymerase chain reaction (PCR) in four
patients from Texas and Mexico (3,4). The
taxonomic position of this organism within the
genus  Rickettsia was assessed by genomic
sequence comparison, following the successful
amplification of a 17-kDa protein gene fragment
from infected flea tissue by PCR with genus-
specific primers (5). In addition, the organism
was found to be transmitted transovarially in
fleas (5) and to be pathogenic in a human patient
(6). In 1995, the name “R. felis” was proposed for
the ELB agent on the basis of its phenotypic
characteristics, as well as its clear genotypic
differences from other known Rickettsia species
(6). The organism was provisionally named “R.
felis” but the name is not formally approved by
International Society for Systematic and Evolu-
tionary Biology as no strain was deposited in any
official collection. In 1997, the ELB agent was
detected in two other flea species in the United
States, C. felis and Pulex irritans (7). Although
isolation in tissue culture was reported (3,8,9),
contamination with R. typhi has hampered
subsequent work (6), so no isolate of R. felis was
available when we began our study.
We describe methods used to cultivate
several isolates of the ELB agent and its
morphologic, antigenic, and genomic characteris-
tics, as well as the results of a serosurvey with
one of our type strains.
Materials and Methods
C. felis fleas (Flea Data Inc., Freeville, NY)
were divided into 20 groups of 5. After surface
sterilization by a 5-minute immersion in 70%
methanol with 0.2% iodine, the fleas were
washed in sterile distilled water and frozen in
liquid nitrogen. Frozen fleas were macerated
with a sterile plastic spatula, suspended in
0.8 mL of culture medium, and injected into shell
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A rickettsia named the ELB agent, or “Rickettsia felis,” was identified by molecular
biology techniques in American fleas in 1990 and later in four patients from Texas and
Mexico. We attempted to isolate this rickettsia from infected fleas at various
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detected reactive antibodies in human sera. The ELB agent was isolated from 19 of 20
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with fever and rash in France (2) and Brazil (2), supporting the pathogenic role of this
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vials. Fifty microliters of the suspension was
retained for use as template in a Rickettsia-
specific PCR targeting a fragment of the citrate
synthase-encoding gene (gltA) (10).
Human embryonic lung fibroblasts (11) or the
XTC-2 cell line derived from Xenopus laevis (12)
were used for isolation by the shell vial
centrifugation technique (6). Subconfluent cell
monolayers were obtained by incubating the shell
vials at 28°C for 48 hours after they were injected
with 50,000 cells in 1 mL of Leibowitz-15 medium
with L-glutamine and L-amino-acids (GIBCO,
Rockville, MD), 5% (v/v) fetal calf serum and 2%
(v/v) tryptose phosphate (GIBCO) for XTC-2
cells, and Minimum Essential Medium (GIBCO)
supplemented with 2 mM L-glutamine and 10%
fetal bovine serum for human embryonic lung
fibroblasts. Before injection with the flea extract,
the medium was removed by aspiration.
After injection of both cell types with
suspensions of five fleas resuspended in 0.8 mL of
the corresponding medium, the shell vials were
centrifuged at 700 X g for 1 hour at 20°C, and the
supernatant was discarded. After two washings
in sterile phosphate-buffered saline (PBS), 1 mL
of fresh medium containing 4 µg/mL
cotrimoxazole, an antibiotic used to prevent
contamination, was added to the shell vials,
which were incubated at 28°C. The cell culture
medium was replaced every 7 days for up to 30
days. When rickettsiae could be detected in cells
in the discarded medium by Gimenez staining
(13), the infected cell monolayer was harvested
and spread onto a subconfluent cell monolayer of
the same cell line in a 25-cm2 tissue culture flask,
which was also incubated at 28°C.
For further studies, we used our first isolate
of the ELB agent, which we named the Marseille
strain. We attempted to infect mammalian cell
lines with the Marseille isolate on monolayers of
Vero, MRC-5, and L-929 cells incubated with 5%
CO2 at 28°C, 32°C, or 37°C, in the same medium
as human embryonic lung fibroblasts. The
ultrastructure of the Marseille isolate was
studied by electron microscopy (14), and the
strain was purified as for other rickettsia (15).
To quantify growth of the ELB agent, 1 µL of
10-1, 10-2, 10-3, 10-4, 10-5, 10-6 dilutions of a
suspension made of rickettsiae harvested from a
25-cm2 tissue culture flask and purified from cells
were deposited onto 30-well microscope slides
(Dynatech Laboratories Ltd., Billingshurt, UK),
air dried, fixed with acetone for 10 minutes, and
then stained by the Gimenez technique. The
number of rickettsiae was estimated visually.
To raise polyclonal antisera against the
Marseille isolate, 6- to 8-week-old Balb C mice
were injected intraperitoneally with 1 mL of a
solution containing v/v 106 purified Marseille
isolate in PBS and complete Freund’s adjuvant.
Inoculation was repeated at 10, 20, and 30 days.
At 40 days, blood was collected by intracardiac
puncture, and sera were stored at –20°C. The
same procedure was performed with R. conorii
(Moroccan strain, ATCC VR 141) and R. typhi
(Wilmington strain, ATCC VR-144).
To determine the prevalence of antibodies
reactive with the organism in the general
population in France, serum specimens from 100
French blood donors were tested by microimmuno-
fluorescence against the Marseille strain; 140
serum samples from Brazilian blood donors,
which had been sent to our laboratory to estimate
the seroprevalence of various rickettsioses, were
also tested. Microimmunofluorescence was also
used to determine cross-reactivity between our
strain of the ELB agent and other rickettsiae.
Convalescent-phase serum specimens from 67
patients with epidemiologic, clinical, and serolog-
ic evidence of epidemic typhus, 16 patients with
murine typhus, and 97 French patients with
fever and rash serologically and clinically
diagnosed as Mediterranean spotted fever, were
tested by microimmunofluorescence for antibod-
ies against R. rickettsii, R. typhi, and the
Marseille strain. Serum samples from 16
Brazilian patients with unexplained febrile rash
were also included in these tests. For microim-
munofluorescence,  R. conorii strain Seven
(Malish), R. rickettsii strain R (Bitterroot),
R. prowazekii strain Brein L, and R. typhi strain
Wilmington were grown in Vero cells and purified
(11). These antigens and the purified suspension
of the Marseille strain described above were
applied at separate sites on each well of 30-well
microscope slides (Dynatech Laboratories, Ltd.),
air dried, and fixed with acetone for 10 min.
Microimmunofluorescence tests were performed
(16), with immunoglobulin (Ig) G and IgM titers
determined separately. To remove antibodies
against any host-cell components, antisera were
absorbed with XTC-2 or Vero cells before being
used in the microimmunofluorescence. More-
over, before detection of IgM, the antisera were
absorbed with rheumatoid factor absorbent
(Behring-Werke AG, Marburg, Germany). The75 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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antisera were then applied to the fixed antigens
at doubling dilutions from 1:4 to 1:2,048 (16).
Analysis of major proteins of the Marseille
isolate by sodium dodecyl-sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) were performed
by using both heated and unheated antigens (17).
Major immunogenic proteins were studied by
Western blot with purified unheated antigens
(14,17).
For PCR amplification and sequencing of
gene fragments from macerated flea suspensions
and rickettsial isolates, genomic DNA was
extracted by using the QIAmp tissue kit (Qiagen,
Hilden, Germany) according to the manufacturer’s
instructions. In addition to the 17-kDa antigen- and
citrate synthase-encoding genes determined by
Azad et al. (5) and Higgins et al., respectively (3),
we amplified and sequenced fragments of the
genes encoding the rickettsial outer membrane
proteins A and B (ompA and ompB). Primers
were designed within conserved regions of the
genes, and amplifications were carried out as
described (Table 1,18). Sequencing reactions with
these primers were done with the dRhodamine
Terminator sequencing kit (PE Applied Biosys-
tems, Warrington, UK). The reaction products
were resolved on 5% polyacrylamide gels (Tebu,
Le Perray en Yvelines, France) by an ABI PRISM
377 DNA sequencer (PE Applied Biosystems).
Amplifications of R. typhi by PCR from
subcultures of the Marseille strain were performed
by using the gltA-derived R. typhi-specific primers
TY1f (5'-TGGGGAACTACCAAGTAGT-3') and
TY1r (5'-ACCAGTGCTAATACATGCAA-3') as
described to determine the purity of the culture.
DNA was extracted as described. DNA from
R. typhi cultured in Vero cells was used as
positive control.
Nucleotide sequences were aligned with
sequences from other Rickettsia species in
GenBank by using the multisequence alignment
software CLUSTAL within the BISANCE
environment (20). The phylogenetic relation-
ships between our strain and other representative
Table 1. Primers used for PCR amplification and sequencing of the ELB agent strain Marseille-URRWFXCal2
  Gene
position
 relative
 to open
Gene    Primer Nucleotide sequence (5'-3') reading frame       Reference
17-kDa antigen 17kDFa GCTCTTGCAACTTCTATGTT     31-50 This manuscript
17KdRa CATTGTTCGTCAGGTTGGCG   464-445 This manuscript
Citrate synthase CSFEL1a TGATTCAGAATTTGCCGAAT     21-40             17
CS890ra GCTTTAGCTACATATTTAGG   890-871             17
CS532ra GCCGCAATGTCTTATAAATATTCT   532-555 This manuscript
CS1273ra CATAACCAGTGTAAAGCTG 1273-1255 This manuscript
CS244rb CTTTAATATCATATCCTCGAT   244-224             17
Rp877Pb GGGGACCTGCTCACGGCGG   797-815             18
rOmpB 120-M59a CCGCAGGGTTGGTAACTGC  M59-M41 This manuscript
120-807a CCTTTTAGATTACCGCCTAA   807-788 This manuscript
120-607a AATATCGGTGACGGTCAAGG   607-626 This manuscript
120-1497a CTATATCGCCGGTAATT 1497-1480 This manuscript
120F-1351a TTTAGGAAACGCTGGTTCTC 1351-1370 This manuscript
120F-2934a GCGTTAGTTGCGATAATACT 2934-2915 This manuscript
120-2788a AAACAATAATCAAGGTACTGT 2788-2808 This manuscript
120-3599a TACTTCCGGTTACAGCAAAGT 3599-3579 This manuscript
120F-3440a GTTAATGCAACAACTACGGG 3440-3459 This manuscript
120F-4341a GCATCGAAGAAGTAACGCTG 4341-4322 This manuscript
120-4232a GGTTTCTCATTCTCTCTATATGG 4232-4254 This manuscript
120-4879a TTAGAAGTTTACACGGACTTT 4879-4857 This manuscript
120F-1749b CTATTAGTGGTAATATTGGTAC 1749-1770 This manuscript
120F-2495b CATGGTCATTACCTGCATTACC 2495-2481 This manuscript
120-4489b GTCTTCTGACGAAAACTACAA 4489-4509 This manuscript
ROmpA 190-70a ATGGCGAATATTTCTCCAAAA     70-90             18
190-701a GTTCCGTTAATGGCAGCATCT   701-681             19
aPrimers used for both PCR amplification and sequencing of the ELB agent strain Marseille-URRWFXCal2.
bPrimers used only for sequencing.76 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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Table 2. Time required to infect 90% of cells in a 174-cm2
cell culture flask after inoculation with 5 x105 ELB agent
strain Marseille-URRWFXCal2
     Incubation temperatures
Cell type   28°C  32°C 37°C
XTC-2 cells   6 days   NDa NDa
Vero cells 14 days 14 days No
MRC-5 cells   NGb   NGb NGb
L-929 cells   NGb   NGb NGb
aND = not done. XTC-2 cells died at temperatures  32°C.
bNG = no growth was obtained
Figure 1. Transmission electron micrograph of the
ELB agent in XTC-2 cells. The rickettsia are free in the
cytoplasm and surrounded by an electron transparent
halo. Original magnification X 30,000.
strains based on the analysis of gltA and ompB
sequences were determined by using the Phylip
software (21). The distance matrix generated by
DNADIST was determined under the assump-
tion of Jukes and Cantor (22) and used to
construct a dendrogram by the neighbor-joining
method (23). Two other dendrograms were
constructed by using data processing with the
maximum-likelihood and parsimony program
DNAPARS. Bootstrap replicates were performed
by using SEQBOOT and CONSENSE in the
PHYLIP software to estimate the node reliability
of the trees obtained by the three methods (24).
To improve the sensitivity of PCR and detect
rickettsial DNA from serum samples, we
designed a nested PCR based on the amplifica-
tion of the gltA gene. DNA was extracted from
200 µL of serum by using the QIAmp blood kit
(Qiagen) as recommended by the manufacturer.
External primers designed for this purpose were
ELB1f (5'-CTGCTTCTTGTCAGTCTAC-3') and
ELB1r (5'-GATTTTTTGTTCAGGGTCTTC-3'), and
internal primers were ELB2f (5'-GGAATCT
TGCGACATCGA-3') and ELB2r (5'-CAGCCTACG
GTTCTTGC-3'). The internal primers encom-
passed a 952-bp gltA fragment allowing a reliable
identification of most rickettsial species after
sequencing (including R. felis,  R. conorii, and
R. rickettsii). Amplification, sequencing of
amplicons, and sequence analysis were done as
described. Forty-seven serum samples were
tested with this technique, 27 from patients with
rickettsial diseases (including those reacting
serologically to the ELB agent) and 20 from blood
donors used as negative controls.
Results
The ELB agent was detected by PCR
amplification of a gltA fragment from all the flea
suspensions used to inoculate the cell culture
monolayers. Initial attempts to isolate the
rickettsia in human embryonic lung fibroblasts
failed, but growth was observed by Gimenez
staining and the rickettsiae were confirmed as
the ELB agent by PCR analysis: 100% homology
was observed with DNA amplified with the gltA
sequence of the ELB agent in 19 of 20
supernatants from the XTC-2 cell monolayers
grown at 28°C 7 and 14 days after inoculation.
R. typhi DNA could not be detected by PCR in any
of the cell culture supernatants, whereas the
primer pair Ty1f and TY1r amplified positive
control DNA.
Initial isolation required 14 days, and
subsequent passages required 6 days to detect
the ELB agent. Cultures of all isolates were
easily established in XTC-2 cells from the 19
suspensions. The reference strain, Marseille-
URRWFXCal2, has been deposited (accession
number I-2363) in the French National Culture
Collection (Institut Pasteur, Paris, France) and
will be sent to the American Type Culture
Collection. Before further studies of this strain,
we reconfirmed by PCR that our strain of the ELB
agent was not contaminated with R. typhi.
The Marseille strain grew most rapidly at
28°C in XTC-2 cells, which died at temperatures
>32°C (Table 2). Human embryonic lung fibroblasts
do not multiply at 28°C, as their optimal growth
temperature is 37°C, and therefore the ELB
agent could not be cultivated in this cell line. The
organism also grew in Vero cells incubated at
either 28°C or 32°C but at half the rate of growth
observed in XTC-2 cells. The MRC-5 and L-929
cell lines were unable to support permanent
growth of the Marseille strain. Electron
microscopy showed the rickettsia to be present
and free in the cytoplasm but not in the nucleus of
the cells (Figure 1).77 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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Figure 2. Phylogenetic tree of members of the genus Rickettsia inferred from comparison of gltA sequences by
using the neighbor-joining method. Bootstrap values for the nodes are indicated.
Four gene fragments were successfully
amplified by PCR, and the base sequences of both
DNA strands of each segment were determined
twice. Nonambiguous sequence data were
obtained between bases 51 and 444 of the 17-kDa
antigen-encoding gene (394 base pairs), bases 41
and 1236 of gltA (1196 bp), bases 91 to 665 of
ompA (575 bp), and bases 1 to 1236 of ompB (1236
bp). Sequences of the 17-kDa protein-encoding
gene and gltA were 100% homologous with those
in GenBank (accession numbers M82878 and
U33922, respectively). The GenBank accession
numbers for the Marseille strain of the ELB
agent nucleotide sequence data reported in this
paper are as follows: citrate synthase-encoding
gene, AF210692; 17-kDa protein-encoding gene,
AF210693; outer membrane protein A-encoding
gene, AF210694; and outer membrane protein B-
encoding gene, AF2106695. Phylogenetic analy-
sis inferred from the comparison of gltA and
ompB nucleotide sequences with the three
analysis methods produced similar organiza-
tions. The ELB agent clustered with R. akari and
R. australis (Figure 2).78 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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The SDS-PAGE profile of the ELB agent differs
from those of R. conorii and R. typhi (Figure 3).
The ELB agent had a high molecular weight
protein with a molecular mass of >150 kDa,
which was not present in R. typhi (Figure 3), as
well as a 30-kDa heat-labile protein not present
in R. typhi or R. conorii. Mouse antisera had a
1:1,600 IgG titer against the ELB agent. In
Western blots (Figure 3), mouse antisera to the
ELB agent reacted strongly with high molecular
mass proteins of the agent, another protein of
about 30 kDa, and the lipopolysaccharide
antigens. Mouse antisera cross-reacted weakly
with the high molecular-mass protein antigens of
R. typhi and R. conorii.
None of the serum specimens from the
French or Brazilian blood donors had substantial
antibody titers against the ELB agent. Of the 67
sera from patients with epidemic typhus, 51
(76%) had antibodies reactive with both
R. prowazekii and the ELB agent; 66 of these sera
had lower titers to the ELB agent than to
R. prowazekii, and one specimen had the same
titer to both organisms. Eleven of the sera from
the 16 patients with murine typhus contained
antibodies reactive with both R. typhi and the
ELB agent, but titers were lower against the ELB
agent in each specimen, except for one with
identical titers to the ELB agent and R. typhi. Of
the 97 sera from patients with suspected
Mediterranean spotted fever, 30 had antibodies
to R. conorii only, and 67 had antibodies reactive
with both R. conorii and the ELB agent, with
titers identical in one patient and greater against
the ELB agent in two patients (patients 1 and 2,
Table 3). These two patients, a woman and a man
from Marseille, had febrile exanthema in 1995
and 1998, respectively. The other 64 patients had
higher antibodies to R. conorii than to the ELB
agent. Among the Brazilian patients with febrile
rash, nine had higher antibody levels to
R. rickettsii, the agent of Rocky Mountain spotted
fever, and the ELB agent; one had higher titers to
R. typhi; and two had higher titers to the ELB
agent (patients 3 and 4, Table 3). These two
patients had fever, rash, vomiting, and stupor.
Patient 3, in whom the ELB agent was identified
by sequencing following nested-PCR amplification
Figure 3. (A) Silver-stained SDS-PAGE of whole-cell protein preparations of Rickettsia conorii, the ELB agent
and R. typhi. Lane 1, R. conorii; lane 2. ELB agent; lane 3, R. typhi; lane 4, heated R. conorii; lane 5, heated ELB
agent; lane 6, heated R. typhi. Molecular weights are indicated on the left. (B) Western blot of rickettsial proteins
probed with various antisera. R. conorii antigens (lanes 2, 6, and 10), ELB agent antigens (lanes 3, 7, and 11) and
R. typhi antigens (lanes 4, 8, and 12) were probed with anti-R. conorii (lanes 2 to 4), anti-ELB agent (lanes 5 to
7) and anti-R. typhi (lanes 8 to 10) polyvalent mouse antisera. Lane 1: molecular weight marker.79 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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from a serum sample, had coma, thrombocytope-
nia 71,000/mL, and aspartate aminotransferase
transaminase 75 IU/mL. Three additional
Brazilian patients had similar titers against
R. rickettsii and the ELB agent. Overall, four
patients were identified as infected by the ELB
agent, and five had equally elevated antibody
levels to the ELB agent and another Rickettsia.
Of the 47 serum samples tested, only two
were positive by the nested PCR. In addition to
detecting the ELB agent in patient 3, this
technique also identified R. rickettsii in a
Brazilian patient who had much higher titers to
R. rickettsii than to the ELB agent. None of the 20
negative controls reacted in the assay.
Conclusions
Several arthropod-borne pathogenic viruses
and bacteria grow more rapidly in the laboratory
at temperatures lower than human body
temperature (25,26). Rickettsia are also better
adapted for growth at low temperatures. One of
the main microbiologic differences between the
typhus and spotted fever groups is their optimal
growth temperatures. While members of both
groups can be maintained in embryonated eggs at
37°C, optimal growth of the typhus group of
rickettsiae is 35°C and of the spotted fever group
is 32°C (27). The ELB agent has genotypic and
phenotypic characteristics typical of the spotted
fever group rickettsiae, and our failure to isolate
the organism at human body temperature
indicates that this relatively high temperature is
not optimal for the efficient recovery of the
organism, as is observed with other human
pathogens (e.g., Mycobacterium leprae, Yersinia
sp.). Our demonstration of the ability of XTC-2
cells to support the growth of the ELB agent
indicates that this cell type is an efficient tool to
test the growth of other Rickettsia species at
lower temperatures. This cell line has also proven
to be a versatile host for Bunyaviridae, including
Bunyaviruses, α -viruses, flaviviruses, and rhab-
doviruses (28).
The use of XTC-2 cells proved effective in
recovering the ELB agent from fleas, with
isolations from 19 of 20 macerated flea samples
positive by PCR for the organism. Other spotted
fever group rickettsia or arthropod-borne bacte-
ria, such as Wolbachia sp. (29) and Bartonella
bacilliformis (30), may also be cultivated more
effectively at lower temperatures by using this
cell line.
A pathogenic role of the ELB agent in four
patients from Texas and Mexico has been
demonstrated by PCR (6,31). However, because
serologic tools for the organism were not
available, the prevalence of infections by the ELB
agent in different areas has yet to be determined.
The ELB agent has been found in several species
of fleas in the United States, including C. felis
and Pulex irritans (5). These fleas, however, are
prevalent worldwide, and we have detected DNA
sequences of the ELB agent in Ethiopian fleas
independently tested for another purpose.
Although we did not obtain Brazilian fleas, we
suspect that the ELB agent has a worldwide
distribution in fleas.
Human infections with the agent also appear
to be widespread, with our results showing that 2
French patients with clinical rickettsial disease
and 2 of 16 Brazilian patients with febrile rash
had high antibody titers to the ELB agent.
Moreover, we confirmed that our PCR serology
consistently identified specific sequences of the
ELB agent in the serum of one patient; four such
cases have been reported (6,30). Our findings
indicate that further specific studies are required
to determine the distribution of the ELB agent
and the prevalence of the agent and associated
infection, but this is the first report from cases
outside the United States and Mexico.
The characteristics of our reference strain of
the ELB agent, Marseille, differ phenotypically
Table 3. Serologic studies of French (patient 1 and 2) and Brazilian (patient 3 and 4) patients with serologic evidence
of infection with the ELB agent
Antibody titers to
Patient ELB agent Rickettsia prowazekii R. typhi R. conorii R. rickettsii
no.   IgG IgM IgG IgM IgG IgM IgG IgM IgG IgM
1 2,048 64   0   0 0   0   64   64  NDa ND
2    512 32   0   0 0   0 128   32  ND ND
3 1,024 64 ND ND 0 64  ND  ND   64  64
4    512 64 ND ND 0 64  ND  ND 128  64
aND: not done80 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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from those reported for the lost R. felis strain (6).
Our strain does not grow at 35°C or 37°C, and its
SDS–PAGE protein profiles and Western blots
differed from those reported for R. felis and
R. typhi (3,7,8). Further studies will determine if
the reactive 30-kDa heat-labile protein observed
on Western blot could be a truncated rOmpA
protein, as predicted by genomic studies (31). By
PCR and sequencing, we identified our isolates as
the ELB agent on the basis of 100% gltA sequence
homology with the sequence available for R. felis
(5,6). Therefore, discrepancies with previously
reported phenotypic findings may result from
contamination of R. felis cultures with R. typhi,
which was reported after experiments by the
group that described R. felis (9). In our
experiments based on PCR techniques, however,
we found no evidence of contamination of our
isolate with R. typhi. To avoid confusion between
the characteristics of our isolate and those of the
previously characterized R. felis, we are
preparing a formal taxonomic characterization of
our isolate of the ELB agent.
In summary, our experiments have demon-
strated the usefulness of XTC-2 cells in isolating
arthropod-associated microorganisms. This cell
culture system allowed us to establish and make
available the Marseille strain of the ELB agent.
In addition, we have identified likely cases of
infection by the ELB agent. The techniques that
we describe should facilitate further studies to
determine the prevalence and clinical spectrum
of infection by this organism in humans.
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